Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Deadly Switzerland ski resort fire was likely started by sparklers attached to champagne bottles, officials say - 2ADHD drugs work, but not the way experts thought
- 3How did Ariana Grande get her Glinda voice? I’m the man behind the magic.
- 4Building a Flourishing Business: Illustrations from Business people
- 5Track down the Ideal Weight reduction Methodology for Your Way of life
- I’m a doctor. Here are 10 science-backed tips to help you get healthier.
- Cocoa Prices Settle Lower on Expectations of Adequate Supplies
- Oil Tanker Carrying Iraqi Cargo Seen Transiting Strait of Hormuz
- Iran war pushes Germany's deficit to 4.2% as growth outlook is cut by 50%
- The most effective method to Decide the Best Auto Crash Attorney for Your Lawful Necessities
- Lucky airplane passengers capture NASA's Artemis 2 moon launch from the sky
- See tonight’s solar storm unfold across the world
- As reefs vanish, assisted coral fertilization offers hope in the Dominican Republic
- ‘Grit’ and relentless perseverance can take a toll on brain health − particularly for people facing social stresses like racism
